Peak6 Investments LLC Viking Therapeutics, Inc. Call Options Transaction History

Peak6 Investments LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$49.84 - $70.47 $2.78 Million - $3.93 Million	55,800 Added 372.0%	70,800 $4.48 Million
Q2 2024 Aug 13, 2024	SELL	$47.39 - $80.2 $497,595 - $842,100	-10,500 Reduced 41.18%	15,000 $795,000
Q1 2024 May 14, 2024	BUY	$17.4 - $94.5 $356,699 - $1.94 Million	20,500 Added 410.0%	25,500 $2.09 Million
Q4 2023 Feb 13, 2024	BUY	$9.24 - $19.64 $46,200 - $98,200	5,000 New	5,000 $93,000
Q2 2023 Aug 11, 2023	SELL	$14.84 - $24.79 $262,668 - $438,783	-17,700 Reduced 62.32%	10,700 $173,000
Q1 2023 May 12, 2023	BUY	$8.08 - $17.33 $229,472 - $492,171	28,400 New	28,400 $472,000

473

65.6M

5.72M

3.39M

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $3.25B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.